Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE)

BACKGROUND: Subcutaneous immunotherapy with high dose grass pollen (typically microgram quantities) was first described over 100 years ago. This treatment suppresses allergen-induced cutaneous late responses, with lesser effects on early responses. We previously reported that repeated 2-weekly intra...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Slovick, Anna, Douiri, Abdel, Kelly, Joanna, Guerra, Andrea, Muir, Rachel, Tsioulos, Konstantinos, Murphy, Caroline, Shamji, Mohamed H, Ying, Sun, Durham, Stephen R, Till, Stephen J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765857/
https://ncbi.nlm.nih.gov/pubmed/23965180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-7022-3-27
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller